ConductScience.org, home

Paper32318059

Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.

Bonifazi F and 7 others. Front Immunol, 2020. Cited by 138 papers, by iCite.

Cite this record

ConductScience Library. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Papers, record 32318059. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32318059

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.
PubMed
Journal
Front Immunol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
138
iCite
Relative citation ratio, by iCite
7.51
iCite
Revised in PubMed
2021-03-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonifazi FFrancesca
2Barbato FFrancesco
3Ravaioli FFederico
4Sessa MMariarosaria
5Defrancesco IIrene
6Arpinati MMario
7Cavo MMichele
8Colecchia AAntonio

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fibrinolytic AgentsMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Hepatic Veno-Occlusive DiseaseMajor topic
PolydeoxyribonucleotidesMajor topic
Postoperative ComplicationsMajor topic
Animals
Humans
Palliative Care
Risk Factors
Transplantation, Homologous

Source PubMed

Download CSV of topics

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130176678EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version).Ultraschall Med2017https://conductscience.org/library/papers/30176678PubMed
225300869Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant2015https://conductscience.org/library/papers/25300869PubMed
326367232Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children.Bone Marrow Transplant2016https://conductscience.org/library/papers/26367232PubMed
49808553
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.
Blood1998https://conductscience.org/library/papers/9808553PubMed
529767845Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.Br J Haematol2018https://conductscience.org/library/papers/29767845PubMed
629789625Clinical diagnosis of veno-occlusive disease using contrast enhanced ultrasound.Bone Marrow Transplant2018https://conductscience.org/library/papers/29789625PubMed
727956374Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.Turk J Haematol2017https://conductscience.org/library/papers/27956374PubMed
822364685Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.Lancet2012https://conductscience.org/library/papers/22364685PubMed
929945939The use of defibrotide in blood and marrow transplantation.Blood Adv2018https://conductscience.org/library/papers/29945939PubMed
103754835Defibrotide therapy for thrombophlebitis--controlled clinical trial.Haemostasis1986https://conductscience.org/library/papers/3754835PubMed
118338943Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial.Blood1993https://conductscience.org/library/papers/8338943PubMed
1230660772
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30660772PubMed
1317241926Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.Biol Blood Marrow Transplant2007https://conductscience.org/library/papers/17241926PubMed
142159315Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.Br J Haematol1990https://conductscience.org/library/papers/2159315PubMed
158110625Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction.Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8110625PubMed
1630266674
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30266674PubMed
1710754451Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.Pharmacology2000https://conductscience.org/library/papers/10754451PubMed
1829928989Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.Biol Blood Marrow Transplant2018https://conductscience.org/library/papers/29928989PubMed
1923680861Defibrotide: properties and clinical use of an old/new drug.Vascul Pharmacol2013https://conductscience.org/library/papers/23680861PubMed
209625683Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.Ann Intern Med1998https://conductscience.org/library/papers/9625683PubMed

See all 123 referencesDownload CSV of references

Cited by87

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.

PMIDTitleJournalYearIn PapersSource
42606689Liver sinusoidal endothelial cells in liver diseases and hepatocellular carcinoma: molecular mechanisms, physiology, and therapies.Mol Biomed2026https://conductscience.org/library/papers/42606689PubMed
42582157Diagnostic delay of veno-occlusive disease in a myelofibrosis patient with pre-transplant transjugular intrahepatic portosystemic shunt: a case report.Front Oncol2026https://conductscience.org/library/papers/42582157PubMed
42506094Evaluation of Prophylactic Defibrotide Use in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multicenter Retrospective Cohort Study.J Pers Med2026https://conductscience.org/library/papers/42506094PubMed
42482898Re-exploration of the pharmacotherapeutic strategy for drug-induced liver injury: a narrative review.Front Med (Lausanne)2026https://conductscience.org/library/papers/42482898PubMed
42469395Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).Bone Marrow Transplant2026https://conductscience.org/library/papers/42469395PubMed
42460105Late-onset Anicteric Veno-occlusive Disease after Haploidentical HSCT: Diagnostic Challenges in the Setting of CMV Reactivation.Mediterr J Hematol Infect Dis2026https://conductscience.org/library/papers/42460105PubMed
42437161Hippo-YAP/TAZ Signaling in Hematological Malignancies: Molecular Mechanisms, Pathway Crosstalk and Therapeutic Potential.Cancer Manag Res2026https://conductscience.org/library/papers/42437161PubMed
42420446Non-genotoxic transplantation and in vivo selection through epitope editing.Nature2026https://conductscience.org/library/papers/42420446PubMed
42237408Chronic arsenic poisoning from a realgar-containing traditional medicine causing hepatic veno-occlusive disease and polyserositis: a case report.J Med Case Rep2026https://conductscience.org/library/papers/42237408PubMed
42187578
Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.
Curr Oncol2026https://conductscience.org/library/papers/42187578PubMed
41928587Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the Liver.CRISPR J2026https://conductscience.org/library/papers/41928587PubMed
41437821Lipid dysregulation after hematopoietic stem cell transplant.Haematologica2026https://conductscience.org/library/papers/41437821PubMed
41397861Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.J Rheumatol2026https://conductscience.org/library/papers/41397861PubMed
41091797Community perceptions and practices on hepatic veno-occlusive disease in Tigray, Ethiopia: An explorative study challenging the attribution to Ageratum conyzoides.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/41091797PubMed
41035660Results From a UK Consensus via Delphi on Practical Considerations Surrounding Risk Assessment and Patient Monitoring for a Prompt Diagnosis of Severe Veno-Occlusive Disease (VOD) in Adults Post-HSCT.EJHaem2025https://conductscience.org/library/papers/41035660PubMed
40919202Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway.Front Microbiol2025https://conductscience.org/library/papers/40919202PubMed
40261550Atypical features of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after inotuzumab ozogamicin in adult patients with acute lymphoblastic leukemia.Blood Res2025https://conductscience.org/library/papers/40261550PubMed
40253530
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial.
Bone Marrow Transplant2025https://conductscience.org/library/papers/40253530PubMed
40216867Liver quad culture chip as a model for radiation injury research.Sci Rep2025https://conductscience.org/library/papers/40216867PubMed
40190874Sinusoidal Obstruction Syndrome Post-allogeneic Transplantation: A Complex Multisystem Challenge.Cureus2025https://conductscience.org/library/papers/40190874PubMed

See all 87 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32318059

GET https://conductscience.org/api/papers/v1/32318059/references?page=2